These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15405879)

  • 1. Treatment of paralysis agitans with dihydro-beta-erythroidine.
    SHAPIRO S; BAKER AB
    Am J Med; 1950 Feb; 8(2):153-9. PubMed ID: 15405879
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrina alkaloids; a colorimetric determination of beta-erythroidine.
    DIETZ EM; FOLKERS K
    J Am Pharm Assoc Am Pharm Assoc; 1946 Feb; 35():48. PubMed ID: 21018227
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrina alkaloids; studies on the constitution of erysodine erysovine and erysopine.
    KONIUSZY F; WILEY PF; FOLKERS K
    J Am Chem Soc; 1949 Mar; 71(3):875-8. PubMed ID: 18113523
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrinan alkaloids and isoflavonoids from Erythrina poeppigiana.
    Tanaka H; Etoh H; Shimizu H; Oh-Uchi T; Terada Y; Tateishi Y
    Planta Med; 2001 Dec; 67(9):871-3. PubMed ID: 11745029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective Total Synthesis of (+)-Dihydro-β-erythroidine.
    Clementson S; Jessing M; Pedersen H; Vital P; Kristensen JL
    J Am Chem Soc; 2019 Jun; 141(22):8783-8786. PubMed ID: 31122014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on Argentine plants; the alkaloids of Erythrina crista galli; chromatographic separation of erythratine and erysodine.
    DEULOFEU V; LABRIOLA R
    J Org Chem; 1947 May; 12(3):486-9. PubMed ID: 20240594
    [No Abstract]   [Full Text] [Related]  

  • 7. The Place of Erythroidines in the History of Neuromuscular Blockers.
    McKenzie AG
    J Anesth Hist; 2019 Jan; 5(1):22-24. PubMed ID: 30922537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Conversion of beta-Erythroidine to Derivatives of the Desmethoxy Series and Some Pharmacological Properties of Apo-beta-Erythroidine.
    Sauvage GL; Berger FM; Boekelheide V
    Science; 1949 Jun; 109(2843):627-8. PubMed ID: 17792400
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a new curarizing agent, dihydro-beta-erythroidine, for the production of muscular relaxation during anesthesia and surgery.
    DRIPPS RD; SERGENT WF
    Anesthesiology; 1947 May; 8(3):241-51. PubMed ID: 20238501
    [No Abstract]   [Full Text] [Related]  

  • 10. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.
    Decker MW; Anderson DJ; Brioni JD; Donnelly-Roberts DL; Kang CH; O'Neill AB; Piattoni-Kaplan M; Swanson S; Sullivan JP
    Eur J Pharmacol; 1995 Jun; 280(1):79-89. PubMed ID: 7498257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of dihydro-beta-erythroidine by a constituent of blood plasma.
    KIRSCHNER LB; STONE WE
    J Pharmacol Exp Ther; 1953 Feb; 107(2):188-96. PubMed ID: 13035656
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular blocking action of dihydro-beta-erythroidine.
    HANNA C; MACMILLAN WH; McHUGO PB
    Arch Int Pharmacodyn Ther; 1960 Mar; 124():445-54. PubMed ID: 14399523
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects in human volunteers of subparalytic doses of dihydro-beta-erythroidine.
    MURPHREE HB
    Clin Pharmacol Ther; 1963; 4():304-10. PubMed ID: 13936717
    [No Abstract]   [Full Text] [Related]  

  • 14. Total syntheses of (+/-)-beta-erythroidine and (+/-)-8-oxo-beta-erythroidine by an intramolecular Diels-Alder cycloaddition of a 2-amidoacrolein.
    He Y; Funk RL
    Org Lett; 2006 Aug; 8(17):3689-92. PubMed ID: 16898793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The toxicity and muscular effect of d-tubocurarine combined with beta-erythroidine, myanesin or evipal.
    BERGER FM; SCHWARTZ RP
    J Pharmacol Exp Ther; 1948 Jul; 93(3):362-7. PubMed ID: 18882142
    [No Abstract]   [Full Text] [Related]  

  • 16. The antagonism between acetylcholine and the curare alkaloids, d-tubocurarine, c-curarine-I, c-toxiferine-II and beta-erythroidine in the rectus abdominis of the frog.
    VAN MAANEN EF
    J Pharmacol Exp Ther; 1950 Jun; 99(2):255-64. PubMed ID: 15437298
    [No Abstract]   [Full Text] [Related]  

  • 17. Total synthesis of (+)-beta-erythroidine.
    Fukumoto H; Takahashi K; Ishihara J; Hatakeyama S
    Angew Chem Int Ed Engl; 2006 Apr; 45(17):2731-4. PubMed ID: 16550620
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of diphenhydramine in treatment of paralysis agitans.
    MOORE MT
    Arch Neurol Psychiatry; 1950 Aug; 64(2):287-9. PubMed ID: 15433643
    [No Abstract]   [Full Text] [Related]  

  • 19. The symptomatic treatment of paralysis agitans with benadryl; report of two cases.
    OWYANG E
    Calif Med; 1950 Jan; 72(1):57. PubMed ID: 15398894
    [No Abstract]   [Full Text] [Related]  

  • 20. Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise.
    Manyam BV
    Mov Disord; 1990; 5(1):47-8. PubMed ID: 2404203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.